nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—S1PR1—forebrain—attention deficit hyperactivity disorder	0.0246	0.0638	CbGeAlD
Fingolimod—S1PR3—cardiovascular system—attention deficit hyperactivity disorder	0.0235	0.0612	CbGeAlD
Fingolimod—S1PR5—midbrain—attention deficit hyperactivity disorder	0.0221	0.0575	CbGeAlD
Fingolimod—S1PR1—cardiovascular system—attention deficit hyperactivity disorder	0.0208	0.054	CbGeAlD
Fingolimod—SPHK1—cardiovascular system—attention deficit hyperactivity disorder	0.0205	0.0534	CbGeAlD
Fingolimod—S1PR5—nervous system—attention deficit hyperactivity disorder	0.0182	0.0473	CbGeAlD
Fingolimod—S1PR5—central nervous system—attention deficit hyperactivity disorder	0.0175	0.0455	CbGeAlD
Fingolimod—S1PR5—cerebellum—attention deficit hyperactivity disorder	0.0171	0.0445	CbGeAlD
Fingolimod—S1PR1—midbrain—attention deficit hyperactivity disorder	0.0162	0.0421	CbGeAlD
Fingolimod—SPHK1—midbrain—attention deficit hyperactivity disorder	0.016	0.0417	CbGeAlD
Fingolimod—CYP4F12—midbrain—attention deficit hyperactivity disorder	0.0154	0.0401	CbGeAlD
Fingolimod—S1PR3—nervous system—attention deficit hyperactivity disorder	0.0151	0.0393	CbGeAlD
Fingolimod—S1PR3—central nervous system—attention deficit hyperactivity disorder	0.0146	0.0378	CbGeAlD
Fingolimod—S1PR5—brain—attention deficit hyperactivity disorder	0.0139	0.0361	CbGeAlD
Fingolimod—S1PR1—nervous system—attention deficit hyperactivity disorder	0.0133	0.0346	CbGeAlD
Fingolimod—SPHK1—nervous system—attention deficit hyperactivity disorder	0.0132	0.0343	CbGeAlD
Fingolimod—S1PR1—central nervous system—attention deficit hyperactivity disorder	0.0128	0.0333	CbGeAlD
Fingolimod—S1PR1—cerebellum—attention deficit hyperactivity disorder	0.0125	0.0326	CbGeAlD
Fingolimod—CYP4F12—cerebellum—attention deficit hyperactivity disorder	0.0119	0.031	CbGeAlD
Fingolimod—S1PR3—brain—attention deficit hyperactivity disorder	0.0116	0.03	CbGeAlD
Fingolimod—S1PR1—brain—attention deficit hyperactivity disorder	0.0102	0.0265	CbGeAlD
Fingolimod—SPHK1—brain—attention deficit hyperactivity disorder	0.0101	0.0262	CbGeAlD
Fingolimod—CYP4F12—brain—attention deficit hyperactivity disorder	0.00968	0.0252	CbGeAlD
Fingolimod—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00333	0.00865	CbGeAlD
Fingolimod—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00312	0.0081	CbGeAlD
Fingolimod—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00214	0.00555	CbGeAlD
Fingolimod—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00206	0.00535	CbGeAlD
Fingolimod—S1PR4—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00202	0.00328	CbGpPWpGaD
Fingolimod—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00201	0.00523	CbGeAlD
Fingolimod—S1PR5—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00201	0.00327	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00201	0.00327	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.002	0.00326	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.002	0.00326	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00198	0.00322	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00196	0.00318	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00196	0.00318	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00194	0.00315	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00194	0.00315	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00194	0.00315	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00191	0.0031	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00191	0.0031	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0019	0.00308	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00188	0.00306	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00188	0.00306	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00186	0.00303	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00186	0.00303	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00186	0.00303	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00183	0.00297	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00183	0.00297	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00183	0.00297	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00182	0.00296	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00182	0.00296	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00176	0.00286	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00175	0.00285	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00175	0.00285	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00173	0.00281	CbGpPWpGaD
Fingolimod—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00172	0.00447	CbGeAlD
Fingolimod—S1PR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00171	0.00278	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0017	0.00277	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00169	0.00275	CbGpPWpGaD
Fingolimod—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00169	0.0044	CbGeAlD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00168	0.00273	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00166	0.00269	CbGpPWpGaD
Fingolimod—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00166	0.0043	CbGeAlD
Fingolimod—S1PR3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00164	0.00267	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00164	0.00267	CbGpPWpGaD
Fingolimod—CYP2E1—brain—attention deficit hyperactivity disorder	0.00163	0.00424	CbGeAlD
Fingolimod—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00163	0.00423	CbGeAlD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00161	0.00262	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00161	0.00262	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00159	0.00259	CbGpPWpGaD
Fingolimod—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00159	0.00414	CbGeAlD
Fingolimod—S1PR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00149	0.00242	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00147	0.00238	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00145	0.00235	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00143	0.00232	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00139	0.00226	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00139	0.00226	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00133	0.00216	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00132	0.00214	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00131	0.00214	CbGpPWpGaD
Fingolimod—CYP2D6—brain—attention deficit hyperactivity disorder	0.00129	0.00336	CbGeAlD
Fingolimod—S1PR3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00128	0.00208	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00128	0.00208	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00128	0.00208	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00127	0.00206	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00127	0.00206	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00127	0.00206	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00127	0.00206	CbGpPWpGaD
Fingolimod—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00124	0.00202	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00123	0.002	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00123	0.002	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00123	0.002	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00122	0.00198	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00122	0.00198	CbGpPWpGaD
Fingolimod—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0012	0.00195	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00118	0.00191	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00116	0.00189	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00115	0.00187	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00187	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.00186	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00114	0.00185	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00113	0.00184	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00113	0.00184	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00112	0.00182	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00112	0.00182	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00112	0.00181	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00111	0.0018	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00111	0.0018	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00111	0.0018	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00111	0.0018	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0011	0.00179	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0011	0.00179	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0011	0.00179	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.0011	0.00178	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.0011	0.00178	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00108	0.00175	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00108	0.00175	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.00175	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.00175	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00107	0.00174	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00106	0.00173	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00106	0.00173	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00106	0.00172	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00106	0.00172	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00106	0.00172	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00103	0.00168	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00103	0.00167	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00103	0.00167	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00103	0.00167	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00103	0.00167	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00103	0.00167	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00165	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.001	0.00163	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.001	0.00163	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000999	0.00162	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000996	0.00162	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000996	0.00162	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000996	0.00162	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000992	0.00161	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000992	0.00161	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000984	0.0016	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000984	0.0016	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000979	0.00159	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000979	0.00159	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000979	0.00159	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000979	0.00159	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000969	0.00157	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000967	0.00157	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000967	0.00157	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000967	0.00157	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00096	0.00156	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000935	0.00152	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000934	0.00152	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000904	0.00147	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0009	0.00146	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.0009	0.00146	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0009	0.00146	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.0009	0.00146	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000889	0.00144	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000884	0.00144	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000878	0.00143	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000867	0.00141	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00085	0.00138	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00085	0.00138	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00085	0.00138	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000836	0.00136	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000818	0.00133	CbGpPWpGaD
Fingolimod—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000794	0.00129	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000787	0.00128	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000777	0.00126	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000776	0.00126	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000749	0.00122	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000747	0.00121	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000747	0.00121	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00073	0.00119	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00073	0.00119	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000721	0.00117	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000718	0.00117	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000694	0.00113	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000694	0.00113	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000679	0.0011	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000679	0.0011	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000679	0.0011	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000668	0.00109	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000655	0.00106	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000653	0.00106	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000653	0.00106	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000647	0.00105	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000631	0.00103	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000631	0.00103	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000631	0.00103	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000631	0.00103	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000611	0.000993	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000607	0.000987	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000607	0.000987	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000601	0.000976	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000601	0.000976	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—COMT—attention deficit hyperactivity disorder	0.000596	0.000969	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000593	0.000964	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000593	0.000964	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000592	0.000963	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000588	0.000956	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000588	0.000956	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000584	0.000949	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000578	0.00094	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000578	0.00094	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000573	0.000931	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000571	0.000928	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000571	0.000928	CbGpPWpGaD
Fingolimod—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000563	0.000916	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000556	0.000903	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000553	0.000898	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000551	0.000896	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000534	0.000868	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000532	0.000865	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000532	0.000865	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000525	0.000853	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000525	0.000853	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000518	0.000843	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000515	0.000837	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000511	0.000831	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000496	0.000806	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000488	0.000793	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000483	0.000785	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000473	0.000768	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000465	0.000755	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000459	0.000746	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000442	0.000719	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000439	0.000714	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000427	0.000695	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000426	0.000692	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000425	0.00069	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000422	0.000685	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000419	0.000681	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000387	0.000629	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000373	0.000606	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000373	0.000606	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000368	0.000599	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000338	0.00055	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000301	0.00049	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000299	0.000487	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000299	0.000486	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000297	0.000483	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—EP300—attention deficit hyperactivity disorder	0.000256	0.000416	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000221	0.000359	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000205	0.000333	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000197	0.000321	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000197	0.000321	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000197	0.00032	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000196	0.000318	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000194	0.000316	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—EP300—attention deficit hyperactivity disorder	0.00019	0.000308	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000179	0.000291	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000174	0.000282	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000159	0.000258	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000123	0.0002	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00012	0.000195	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00012	0.000195	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000118	0.000192	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00011	0.000178	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.58e-05	0.000156	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.12e-05	0.000148	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.51e-05	0.000138	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	8.51e-05	0.000138	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	8.37e-05	0.000136	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.06e-05	0.000131	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.78e-05	0.000126	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	7.26e-05	0.000118	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.21e-05	0.000117	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.8e-05	0.000111	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.47e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.56e-05	9.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.56e-05	9.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.47e-05	8.89e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	5.15e-05	8.38e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	5.12e-05	8.32e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.09e-05	8.27e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.45e-05	7.23e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.23e-05	6.88e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.37e-05	5.48e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.35e-05	5.44e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.11e-05	5.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.21e-05	3.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.44e-05	2.35e-05	CbGpPWpGaD
